Similarly, TLR2, A20, NIK and the ratio of p52/p100 were consistently elevated in bone marrow or blood cells from patients with AML harboring comutations in TET2 and TP53 (Figure 5D and Supplemental Table 2). This evidence concerns the gene TET2 and acute myeloid leukemia.